Delivery Order SPE2DB24D1205-SPE2DB24FCSQF

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,546.40 firm fixed-price delivery order is for the supply of 4567027134 - CITALOPRAM HBR 40 MG TABLET 500S. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,473,890 units of Citalopram HBR 40 mg tablets. The fixed-price delivery order has a ceiling value of $28,331.92 and an ultimate completion date of October 16, 2023. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This federal contract award, valued at $2,262.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under the existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the delivery of 4,566,619,263 units of Citalopram HBR 40mg tablets, a generic antidepressant medication. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,929.23, is a delivery order for the supply of 4,567,011,559 units of Citalopram HBr 40 mg tablets. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,670.19 delivery order contract is for the supply of 4,566,612,973 units of Citalopram HBR 40 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing...
This federal contract award, valued at $1,129.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,564,222,913 units of Citalopram HBR 40 mg tablets, with an ultimate completion date of April 10, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,869.83 firm fixed-price delivery order is for the supply of Citalopram HBR 40 mg tablets, with a performance period ending on September 25, 2024. The contract is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order (SPE2DB22D2007|SPE2DB24FH6LS) from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,928.14 firm fixed price contract is for the delivery of 500 units of the drug Citalopram HBR 40 mg tablets. The award has an ultimate completion date of October 23, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,956.97 firm fixed-price delivery order covers the supply of 4,562,704,214 units of Citalopram HBR 40 mg tablets to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,567.95, is for the delivery of 4,565,190,581 units of Citalopram HBR 40 mg tablets. The award is a Firm Fixed Price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCSQF
    Delivery Order

This federal contract award, valued at $6,447.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, covers the supply of Citalopram HBR 40 mg tablets. This contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries, with Amerisourcebergen providing a comprehensive range of pharmaceutical products and medical supplies. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.

Generated 5/17/25, 10:06 AM